Filing Details
- Accession Number:
- 0001104659-24-123806
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-27 19:08:07
- Reporting Period:
- 2024-11-25
- Accepted Time:
- 2024-11-27 19:08:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1377121 | Protagonist Therapeutics Inc | PTGX | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1120477 | D Ph V Dinesh Patel | C/O Protagonist Therapeutics, Inc. 7707 Gateway Blvd., Suite 140 Newark CA 94560-1160 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-25 | 78,520 | $46.96 | 435,208 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-11-25 | 7,000 | $0.00 | 428,208 | No | 4 | G | Direct | |
| Common Stock | Acquisiton | 2024-11-25 | 1,727 | $21.58 | 429,935 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-26 | 21,480 | $46.25 | 408,455 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-11-25 | 1,727 | $0.00 | 1,727 | $21.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 318,273 | 2026-10-11 | No | 4 | M | Direct |
Footnotes
- The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $46.50 to $47.47. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- Includes an aggregate of 313 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2024.
- On November 25, 2024, the Reporting Person made a charitable donation of 7,000 shares of common stock to a donor-advised fund, which will use the gifted shares for charitable purposes.
- The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $44.49 to $46.50. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- These stock options are fully vested.
Billionaire Hedge Funds
